DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7tc5bc/global_type_2) has announced the addition of the "Global Type 2 Diabetes Epidemiology and Patient Flow Analysis - 2012" report to their offering.
Fore Pharma announced the results of its Type 2 Diabetes patient population study in a new report Global Type 2 Diabetes Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Type 2 Diabetes epidemiology, Type 2 Diabetes diagnosed patients, and Type 2 Diabetes treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Type 2 Diabetes derived from epidemiological analysis, percentage of patients diagnosed with Type 2 Diabetes, and percentage of patients treated with Type 2 Diabetes therapy.
The study helps executives estimate Type 2 Diabetes market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Type 2 Diabetes prevalence, Type 2 Diabetes diagnosis rate, and Type 2 Diabetes treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
For more information visit http://www.researchandmarkets.com/research/7tc5bc/global_type_2